Moreover, TIMP2*IGFBP7 levels were found to be associated with the severity of AKI, and certain levels clearly identify patients with further need of renal replacement therapy or contrariwise rule out the need of renal replacement therapy in the next 48 h of observation [33]. This evidence concerns the gene IGFBP7 and acute kidney injury.